These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8912842)

  • 1. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
    Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
    Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.
    Breit TM; Wolvers-Tettero IL; van Dongen JJ
    Oncogene; 1994 Jul; 9(7):1847-53. PubMed ID: 8208530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ; Robb L; Strasser A; Begley CG
    Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin immunoselection defines a TAL-1 target gene.
    Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
    EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
    Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
    Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
    Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
    Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
    Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
    Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.
    Anderegg B; Horstmann M; Kabisch H
    Cancer Gene Ther; 1997; 4(2):84-90. PubMed ID: 9080116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
    O'Neil J; Billa M; Oikemus S; Kelliher M
    Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCL and related hemopoietic helix-loop-helix transcription factors.
    Green AR; Begley CG
    Int J Cell Cloning; 1992 Sep; 10(5):269-76. PubMed ID: 1453013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
    Shivdasani RA; Mayer EL; Orkin SH
    Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.
    Kelliher MA; Seldin DC; Leder P
    EMBO J; 1996 Oct; 15(19):5160-6. PubMed ID: 8895560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene.
    Bernard O; Lecointe N; Jonveaux P; Souyri M; Mauchauffé M; Berger R; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1991 Aug; 6(8):1477-88. PubMed ID: 1886719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line.
    Elwood NJ; Cook WD; Metcalf D; Begley CG
    Oncogene; 1993 Nov; 8(11):3093-101. PubMed ID: 8414511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
    Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
    J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse carrying genetic defect in the choice between T and B lymphocytes.
    Tokoro Y; Sugawara T; Yaginuma H; Nakauchi H; Terhorst C; Wang B; Takahama Y
    J Immunol; 1998 Nov; 161(9):4591-8. PubMed ID: 9794386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny.
    Giroux S; Kaushik AL; Capron C; Jalil A; Kelaidi C; Sablitzky F; Dumenil D; Albagli O; Godin I
    Gene Expr Patterns; 2007 Jan; 7(3):215-26. PubMed ID: 17112790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.